Detail
| LncRNA Name | CASC2 |
| Synonyms | CASC2, C10orf5 |
| Region | GRCh38_10:118046279-118210153 Sequence |
| Ensembl | ENSG00000177640 |
| RefSeq | NR_026939 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | osteosarcoma |
| ICD-0-3 | M9180/3 |
| Methods | qPCR |
| Sample | cell lines (143B, U.2 OS, KHOS.240S, D22, Saos.2, HOS and MG.63,hFOB) |
| Expression Pattern | down-regulated |
| Function Description | CASC2 transduction may decrease proliferation, migration and invasion of osteosarcoma cell lines whereas knockdown of CASC2 displayed opposing effects.Patients with low CASC2 levels were predicted to have a poor survival. |
| Pubmed ID | 29257211 |
| Year | 2017 |
| Title | The long noncoding RNA cancer susceptibility candidate 2 inhibits tumor progression in osteosarcoma. |
| External Links |
| Links for CASC2 | GenBank HGNC lncrnadb Noncode |
| Links for osteosarcoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.